# Anas Younes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anas-younes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,097 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 101 |
| i10-index | 407 |
| Last Known Institution | Intercept Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5068152076 |
| ORCID iD | https://orcid.org/0000-0002-0001-4133 |
| Works | 845 |

## Researcher papers

- [Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial](https://scholariq.org/papers/lenalidomide-in-combination-with-rituximab-for-patients-with-relapsed-or/)
- [Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma](https://scholariq.org/papers/selective-inhibition-of-hdac3-targets-synthetic-vulnerabilities-and-activates/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)

## Researcher university

- [Intercept Pharmaceuticals (United States)](https://scholariq.org/institutions/intercept-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.